Researchers unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues

Apr 8, 2024

In a study published by the Institute for Research in Biomedicine (IRB Barcelona) and the PCCB-Sant Joan de Déu Hospital · Sant Joan de Déu Research Institute (HSJD—IRSJD) in the journal Cancer Discovery,, a team of scientists has made significant progress in understanding the origin of childhood cancer.

Comments

HRD HSCT Shows Promise Among Pediatric Patients With Hematologic Cancers

Treating a deadly childhood cancer with a sideways approach

Childhood Cancer Survivors Have Higher Risk of Chronic Conditions, Early Death

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia

Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

Is Less More? Rethinking Salvage Therapy in Pediatric Hodgkin Lymphoma

Newborns with heart defects may face a higher risk of developing childhood cancer

New therapeutic approach shows promise for pediatric high-grade gliomas

Space-age lessons could protect childhood cancer survivors’ bone health

Recent Posts